Should Familial Hypercholesterolaemia Be Included in the UK Newborn Whole Genome Sequencing Programme?

Steve E Humphries1, Uma Ramaswami2, Neil Hopper3

  • 1Centre for Cardiovascular Genetics, Rayne Building, 5 University Street, University College London, London, United Kingdom, WC1E 6JJ.

PubMed

Insights

Familial hypercholesterolaemia (FH) should be included in the UK Newborn Genomes Programme (NGP). Early detection via whole genome sequencing (WGS) enables timely treatment, improving health outcomes for infants with this inherited condition.

Area of Science:

  • Genomics and Genetic Screening
  • Public Health Initiatives
  • Cardiovascular Disease Prevention

Background:

  • The UK National Health Service (NHS) is launching a Newborn Genomes Programme (NGP).
  • This program aims to identify infants with treatable inherited disorders using whole genome sequencing (WGS).
  • Familial hypercholesterolaemia (FH) is a key focus for potential inclusion.

Purpose of the Study:

  • To evaluate Familial Hypercholesterolaemia (FH) against the four key principles for inclusion in the Newborn Genomes Programme (NGP).
  • To determine if FH meets the criteria for genetic screening in newborns.

Main Methods:

  • Assessment of FH against established criteria for newborn screening programs (Wilson and Jungner criteria).
  • Evaluation of FH based on four specific principles: reliable genetic detection, risk of early heart disease, benefit of early intervention, and equitable access to treatment.

Main Results:

  • Principle A: Genetic variants causing FH are reliably detectable.
  • Principle B: Individuals with FH variants face a high risk of early heart disease without diagnosis and treatment.
  • Principle C: Early intervention significantly improves outcomes for children with FH.
  • Principle D: Recommended interventions for FH are equitably accessible.

Conclusions:

  • Familial Hypercholesterolaemia (FH) meets all four principles required for inclusion in the Newborn Genomes Programme (NGP).
  • FH also satisfies the Wilson and Jungner criteria for screening programs.
  • FH is strongly recommended for inclusion in the Newborn Genomes Programme for early detection and intervention.
Abstract

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.5K
Next-generation Sequencing03:00

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
89.0K
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
7.6K